ஐ.எஸ்.எஸ்.என்: 0974-276X
எம் வாலிட் குரோன்ஃப்லே
This concept communication describes a mass spectrometry workflow specific to biomarker assay development and validation. The primary objective of this workflow is to significantly decrease the cost and timeline for assay development and biomarker validation. The biomarker development workflow can be separated into five development stages that take less than 6 months to complete.